<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Up to now the existence of "vascular <z:hpo ids='HP_0001300'>parkinsonism</z:hpo>" has been doubtful because conclusive clinicopathologic studies are lacking </plain></SENT>
<SENT sid="1" pm="."><plain>The objective of the present magnetic resonance spectroscopy (MRS) study is to detect metabolic signs as a reflect of ischemic lesions which could be responsible for the clinical features of vascular <z:hpo ids='HP_0001300'>parkinsonism</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Proton MRS of the brain was performed in 12 patients suspected of vascular <z:hpo ids='HP_0001300'>parkinsonism</z:hpo> on clinical grounds and ischemic score, and in a control group of 15 patients with <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">idiopathic Parkinson's disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> spectra were measured in the striatum and deep white matter </plain></SENT>
<SENT sid="4" pm="."><plain>MRS did not demonstrate metabolic evidence for the existence of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (elevated <z:chebi fb="4" ids="24996">lactate</z:chebi>) or cell loss (decreased N-<z:chebi fb="9" ids="46887">acetyl</z:chebi>-<z:chebi fb="0" ids="29995">aspartate</z:chebi> levels) in patients suspected of vascular <z:hpo ids='HP_0001300'>parkinsonism</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Several explanations for our findings are discussed </plain></SENT>
</text></document>